title: Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia?
abstract: The cut-off values able to differentiate between reactive or neoplastic C-cell hyperplasia (CCH) or to predict sporadic medullary thyroid cancer (MTC) are still debated both for basal and stimulated calcitonin (bCT and sCT). In the present study, the prevalence and the histological patterns of CCH in 15 patients with multinodular goiter (MNG), bCT>10 pg/ml and sCT levels >50 pg/ml were studied. As controls, 16 patients with MNG and bCT levels <10 pg/ml and 4 patients with familial (FMTC) were included. For each case, calcitonin (CT) immunoreactive cells were counted in 60 consecutive high-power fields (400x) and CCH classified as focal, diffuse, nodular, or neoplastic. RET genetic analyses were performed at the germline and tissue levels in MTC and CCH cases. In patients with MNG, sCT levels >50 pg/ml were associated with CCH or MTC, being the total number of C-cells/60 fields significantly higher than that found in MNG with normal bCT (P = 0.0008) and comparable with that detected in FMTCs. In the group with sCT>50 pg/ml, the C-cells displayed a neoplastic phenotype. Neither germline nor somatic RET mutations were found. In conclusion, sCT levels >50 pg/ml were always associated with CCH, without correlation between CT levels and the number of C-cells or the final diagnosis. The C-cells had a morphology and distribution pattern similar to those observed in FMTC. Thus, sCT levels >50 pg/ml indicate the presence of CCH with a possible preneoplastic potential, suggesting the opportunity to perform a prophylactic surgical treatment.
authors.affiliation: Endocrine Unit, Department of Medical Sciences, University of Milan and Fondazione Policlinico IRCCS, Milan, Italy.
authors.forename: Uberta
authors.initials: U
authors.lastname: Verga
authors.forename: Stefano
authors.initials: S
authors.lastname: Ferrero
authors.forename: Leonardo
authors.initials: L
authors.lastname: Vicentini
authors.forename: Tatiana
authors.initials: T
authors.lastname: Brambilla
authors.forename: Valentina
authors.initials: V
authors.lastname: Cirello
authors.forename: Marina
authors.initials: M
authors.lastname: Muzza
authors.forename: Paolo
authors.initials: P
authors.lastname: Beck-Peccoz
authors.forename: Laura
authors.initials: L
authors.lastname: Fugazzola
mesh_terms: D000328:Adult; D000368:Aged; D020295:Brain Stem Neoplasms / Q000175:diagnosis / Q000473:pathology*; D002116:Calcitonin / Q000097:blood*; D005260:Female; D006044:Goiter, Nodular / Q000175:diagnosis / Q000473:pathology*; D006801:Humans; D006965:Hyperplasia / Q000175:diagnosis / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009154:Mutation; D051096:Proto-Oncogene Proteins c-ret / Q000235:genetics; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000473:pathology*
chemical_list: D002116:Calcitonin; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human